PUXEDDU, ILARIA
 Distribuzione geografica
Continente #
EU - Europa 20.140
NA - Nord America 3.942
AS - Asia 1.552
SA - Sud America 171
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 2
Totale 25.841
Nazione #
IT - Italia 19.237
US - Stati Uniti d'America 3.904
SG - Singapore 658
CN - Cina 586
UA - Ucraina 338
SE - Svezia 167
BR - Brasile 130
FI - Finlandia 124
VN - Vietnam 106
DE - Germania 86
FR - Francia 78
GB - Regno Unito 55
BD - Bangladesh 43
HK - Hong Kong 38
KR - Corea 31
IN - India 26
CA - Canada 24
EU - Europa 14
IQ - Iraq 14
AR - Argentina 13
RU - Federazione Russa 13
NL - Olanda 12
CO - Colombia 10
ZA - Sudafrica 9
VE - Venezuela 7
ES - Italia 6
PS - Palestinian Territory 6
DZ - Algeria 5
JP - Giappone 5
MX - Messico 5
PH - Filippine 5
ID - Indonesia 4
MY - Malesia 4
PK - Pakistan 4
TH - Thailandia 4
AZ - Azerbaigian 3
CL - Cile 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
MA - Marocco 3
PL - Polonia 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
IE - Irlanda 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
MD - Moldavia 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TO - Tonga 1
Totale 25.841
Città #
Cagliari 18.936
Fairfield 443
Woodbridge 397
Ashburn 332
Singapore 304
Houston 270
Chandler 251
Jacksonville 185
Dallas 178
San Jose 167
Ann Arbor 166
Seattle 166
Wilmington 166
Uta 156
Cambridge 147
Boardman 145
Beijing 130
Nyköping 120
Nanjing 70
Helsinki 64
Los Angeles 60
Santa Clara 57
Dearborn 54
Lauterbourg 53
Boston 47
Hefei 44
Ho Chi Minh City 35
Hong Kong 35
Seoul 31
Shanghai 30
The Dalles 27
Buffalo 25
Hanoi 25
Nanchang 25
Council Bluffs 20
San Diego 18
Shenyang 18
New York 17
Redondo Beach 17
Hebei 15
Toronto 14
Changsha 13
Milan 11
Norwalk 11
São Paulo 11
Jiaxing 10
Jinan 10
Tianjin 10
Kunming 9
Baghdad 8
Guangzhou 8
Stockholm 8
Turku 8
Da Nang 7
Frankfurt am Main 7
Monsummano Terme 7
Ningbo 7
Rio de Janeiro 7
Verona 7
Brasília 6
Chicago 6
London 6
Mountain View 6
Washington 6
Zhengzhou 6
Augusta 5
Dhaka 5
Haiphong 5
Johannesburg 5
Medellín 5
Millbury 5
Munich 5
Phoenix 5
San Francisco 5
Serra 5
Tokyo 5
Chennai 4
Curitiba 4
Dong Ket 4
Düsseldorf 4
Meppel 4
Pittsburgh 4
Rome 4
St Louis 4
Albuquerque 3
Algiers 3
Atlanta 3
Baku 3
Belo Horizonte 3
Brooklyn 3
Campinas 3
Caracas 3
Columbus 3
Conway 3
Denver 3
Greenville 3
Miami 3
Pune 3
Ramallah 3
Redwood City 3
Totale 23.790
Nome #
Salivary gland pathology in IgG4-related disease: A comprehensive review 2.127
Parotid mass as an early sign of Kaposi's sarcoma associated with human herpesvirus 8 infection 1.055
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis 715
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases 709
Effect of rheumatoid arthritis (RA) susceptibility genes on the immune response to viral citrullinated peptides in RA 666
Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab 659
Angiogenesis in spondyloarthritis: target for new diagnostic approaches 658
Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant 655
Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts 655
Defective epithelial barrier function in asthma 648
Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis. 638
Two Takayasu arteritis patients successfully treated with rituximab. 637
Endostatin and Thrombospondin-1 levels are increased in the sera of patients with chronic spontaneous urticaria 636
CCL5/RANTES, sVCAM-1, and sICAM-1 in chronic spontaneous urticaria 610
Eotaxin-2/CCL24 and eotaxin-3/CCL26 exert differential profibrogenic effects on human lung fibroblasts. 600
Antibodies to a new viral citrullinated peptide, VCP2: fine specificity and relation with anti-CCP and anti-VCP1 590
HLA Shared Epitope and ACPA: just a marker or an active player? 566
CCL5/RANTES in ANCA-associated small vessel vasculitis 566
Cell surface expression of Activiting Receptors and co-receptors on peripheral blood NK cells in mixed cryoglobulinemia 560
The endogenous angiostatic mediators endostatin and thrombospondin-1 are increased in spondyloarthritis 537
Mycophenolic acid suppresses human pterygium and normal tenon fibroblast proliferation in vitro. 512
Osteopontin is expressed and functional in human eosinophils 499
Mast cells and Eosinophils: a novel link between inflammation and angiogenesis in allergic diseases 403
Mast cells and eosinophils: the hallmark of asthma 399
Nerve Growth Factor effect on human primary fibroblstic-kerstocyte: possible mechanism during corneal healing 388
Human Mast Cells release Oncostatin M on contact with activated T cells: possible biologic relevance 387
The pro-fibrogenic effect of Nerve Growth Factor on conjunctival fibroblasts is mediated by transforming growth factor beta 382
Effects of dexamethasone on TNF-alpha-induced release of cytokines from purified human blood eosinophils 372
The CC-chemokine Eotaxin/CCL11 has a selective pro-fibrogenic effect on human lung fibroblasts 370
Hypoxia modulates human eosinophils signalling and function 363
Osteopontin (Opn) is expressed and functional in human peripheral blood eosinophils 360
Angiogenesis in asthma. 356
Eotaxin-1/CCL11 and Eotaxin-2/CCL24 expression and eosinophilic airway inflammation in OVA-challenged BALB/c mice 349
The solubile form of a disintegrin and metalloprotease 33 promotes angiogenesis: Implications for airway remodeling in asthma 346
Human peripheral blood eosinophils induce angiogenesis 337
Enhanced osteopontin expression in a murine model of allergen-induced airway remodeling. 328
Mast cells induce activation of human lung fibroblasts in vitro 328
Eosinophil-derived Major Basic Protein induces angiogenesis 326
Eosinophil major basic protein: first identified natural heparanase-inhibiting protein. 324
Immune effector cells: mast cells and eosinophils? 313
Nerve growth factor-a neurotrophin with angiogenic activity 312
Nerve Growth Factor (NGF) activates conjunctival myofibroblasts: a role for NGF in healing process and tissue remodeling 303
Nerve Growth factor and eosinophils in inflamed juvenile conjunctival nevus 301
Human mast cells release oncostain (OSM) specifically on contact with activated T cells 295
New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis 295
Osteopontin is expressed in human peripheral blood eosinophils and contributes to their pro-angiogenic activity 290
Human cord blood-derived mast cells adhere to extracellular matrix proteins by functional alpha 4 beta 1 (CD49d/CD29), alpha 5 beta 1 (CD49e/CD29), alpha 4 beta 7 integrins and CD44 287
Mast cells in allergy and beyond 283
Fibrosis in ocular allergic inflammation – recent concepts in the pathogenesis of ocular allergy 282
Inhaled corticosteroids modulate eosinophil pro-fibrogenic effects in childhood asthma. 278
Nerve Growth Factor (NGF) modulates in vitro cultured human derived keratocyte activities: a potential collaborative effect with TGF-neta 1 278
Mast cells in tissue remodelling 261
Role of eosinophils in angiogenesis 252
Suppression of fibrotic responses by mycophenolic acid in human tenon fibroblasts in vitro 232
Totale 25.878
Categoria #
all - tutte 43.260
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.260


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 0 0 0 0 0 0 113
2021/2022679 63 76 39 52 30 48 39 74 53 39 55 111
2022/20231.496 118 114 84 108 94 210 49 436 94 56 73 60
2023/20241.877 164 95 124 193 247 155 116 145 107 204 147 180
2024/20251.554 97 105 255 120 207 146 111 58 161 90 109 95
2025/20261.907 176 99 321 138 170 110 353 65 140 146 142 47
Totale 25.878